CSL to acquire Novartis influenza vaccines business, including development pipeline, for USD 275 million Announcement follows a transaction announced on April 22, 2014 to divest the non-influenza segments of Novartis Vaccines to GlaxoSmithKline Basel, Switzerland, 28-10-2014 — /EuropaWire/ — Novartis today … Read the full press release
Posted in Business, Healthcare, Pharma & Biotech, Switzerland
Tagged CSL, CSL Limited, Eric Althoff, influenza vaccines business, Joseph Jimenez, Liz Power, Novartis
KAE609 is the first antimalarial drug candidate with a novel mechanism of action to achieve positive clinical proof-of-concept in over 20 years KAE609 was tested in adult patients with uncomplicated malaria and showed a median parasite clearance time of 12 … Read the full press release
The International Biotechnology Leadership Camp (BioCamp) fosters idea exchange with leading scientists as well as entrepreneurship for young talents 60 selected students from leading international universities attend to explore science and innovation at Novartis headquarters in Basel, Switzerland Novartis CEO … Read the full press release
Posted in Education, Healthcare, Pharma & Biotech, Science, Switzerland
Tagged Anja von Treskow, Basel, BioCamp, Eric Althoff, healthcare entrepreneur competition, International Biotechnology Leadership Camp, Isabella Zinck, Jill Pozarek, Joseph Jimenez, Novartis, Pierre-Michel Bringer, Prof. Susan Gasser, Rolf M. Zinkernagel M.D., Samir Shah, Stephen Rubino, Thomas Hungerbuehler
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?